SOM Biotech
PrivateLast Round
VC Round
Mar 12, 2024
Total Funding Raised
$28.39M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SOM Biotech operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a VC Round in March 2024.
SOM Biotech is a biopharmaceutical company that discovers and develops drugs for the treatment of rare and critical diseases using a proprietary AI-based drug discovery technology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SOM Biotech Comparables
Compare SOM Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delta4 | 84% | |
| Healx | 82% | |
| DR.NOAH Biotech | 82% |
For institutional investors. Book with your work email.
SOM Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 12, 2024 | ||||
| Series B | Nov 1, 2023 | ||||
| Series A | Mar 7, 2019 | ||||
| Seed | Jan 20, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SOM Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Investment Bank Group | Series B |
| Prevail Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 75% MoM.
- Apr 18, 2026
Monthly visitors increased 56% MoM.
For institutional investors. Book with your work email.
SOM Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SOM Biotech's valuation, stock price, and market status.
Is SOM Biotech a public or private company?
SOM Biotech is a private company.
What is the current stock price of SOM Biotech?
SOM Biotech is a private company, so its shares have no public market price. Caplight tracks SOM Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SOM Biotech worth (valuation)?
Valuation information for SOM Biotech is not publicly available.
Can I buy SOM Biotech stock?
SOM Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SOM Biotech's last funding round?
SOM Biotech's most recent funding round was VC Round on March 12, 2024.
Who are the main investors in SOM Biotech?
Key investors in SOM Biotech include European Investment Bank Group, Prevail Partners.
Will SOM Biotech IPO soon?
No public IPO plans have been announced for SOM Biotech.
How can I track SOM Biotech secondary market activity?
Caplight tracks bids, offers, and trades in SOM Biotech's shares on secondary markets.